Strategic Global Advisors, LLC Gsk PLC Transaction History

Strategic Global Advisors, LLC

$502 Million
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$42.05 - $47.77 $380,720 - $432,509	-9,054 Reduced 62.6%	5,409 $235,000
Q1 2022 May 16, 2022	BUY	$40.23 - $47.74 $199,460 - $236,694	4,958 Added 52.16%	14,463 $630,000
Q4 2021 Feb 14, 2022	BUY	$38.88 - $45.31 $369,554 - $430,671	9,505 New	9,505 $1.88 Million
Q3 2021 Nov 15, 2021	SELL	$38.79 - $43.16 $1.52 Million - $1.7 Million	-39,310 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$36.52 - $41.46 $8,034 - $9,121	220 Added 0.56%	39,310 $1.57 Million
Q1 2021 May 14, 2021	BUY	$34.27 - $40.01 $3,872 - $4,521	113 Added 0.29%	39,090 $1.4 Million
Q4 2020 Feb 16, 2021	SELL	$34.07 - $39.94 $490,165 - $574,616	-14,387 Reduced 26.96%	38,977 $1.43 Million
Q3 2020 Nov 13, 2020	BUY	$38.11 - $42.99 $388,645 - $438,412	10,198 Added 23.63%	53,364 $2.01 Million
Q2 2020 Aug 13, 2020	BUY	$37.87 - $43.58 $757,324 - $871,512	19,998 Added 86.32%	43,166 $1.76 Million
Q1 2020 May 14, 2020	SELL	$32.47 - $48.83 $8,020 - $12,061	-247 Reduced 1.05%	23,168 $878,000
Q4 2019 Feb 13, 2020	BUY	$42.0 - $48.25 $3,192 - $3,667	76 Added 0.33%	23,415 $1.1 Million
Q3 2019 Nov 13, 2019	BUY	$40.46 - $43.52 $4,126 - $4,439	102 Added 0.44%	23,339 $996,000
Q2 2019 Aug 13, 2019	BUY	$39.4 - $42.7 $5,949 - $6,447	151 Added 0.65%	23,237 $930,000
Q1 2019 May 13, 2019	BUY	$38.57 - $42.69 $621,401 - $687,778	16,111 Added 230.98%	23,086 $965,000
Q4 2018 Feb 13, 2019	BUY	$37.8 - $42.69 $6,992 - $7,897	185 Added 2.72%	6,975 $267,000
Q3 2018 Nov 14, 2018	SELL	$39.75 - $42.69 $224,945 - $241,582	-5,659 Reduced 45.46%	6,790 $273,000
Q1 2018 May 14, 2018	BUY	$36.18 - $40.15 $8,791 - $9,756	243 Added 1.99%	12,449 $486,000
Q3 2017 Nov 13, 2017	BUY	$39.44 - $41.55 $481,404 - $507,159	12,206	12,206 $496,000

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Global Advisors, LLC with notifications on news.

Account